BOW

Bowhead Specialty Holdings Inc

Add to Watchlist

Advanced Chart

31.990

-0.71(-2.171%)1D

Overview
Forecast
Valuation
Earnings

Line

Candle

YTD

High

32.700

Open

32.680

VWAP

Vol

306.73K

Mkt Cap

1.04B

Low

31.700

Amount

EV/EBITDA(TTM)

9.92

Total Shares

32.66M

980.02M

EV/OCF(TTM)

3.27

P/S(TTM)

2.31

Bowhead Specialty Holdings Inc. is an insurance holding company. The Company provides specialty property and casualty insurance products in the United States. It conducts its business operations through three wholly owned subsidiaries, such as Bowhead Specialty Underwriters, Inc. (BSUI), Bowhead Insurance Company, Inc. (BICI), and Bowhead Underwriting Services, Inc. (BUSI). Its Casualty division provides solutions on a primary and excess basis through a wholesale-only distribution channel. Its Professional Liability division provides underwriting solutions on both an admitted and excess and surplus (E&S) basis for standard and nonstandard risks and writes for a broad variety of entities, including publicly traded and privately held financial institutions as well as not-for-profit organizations. Its Healthcare division focuses solely on healthcare entities to provide tailored solutions. It offers Professional and General Liability coverage, as well as Management Liability coverage.

3 Analyst Rating

28.17% Upside

Wall Street analysts forecast BOW stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for BOW is 41.00 USD with a low forecast of 39.00 USD and a high forecast of 45.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

1 Buy

2 Hold

0 Sell

Moderate Buy

28.17% Upside

Current: 31.990

Low

39.00

Averages

41.00

High

45.00

28.17% Upside

Current: 31.990

Low

39.00

Averages

41.00

High

45.00

Morgan Stanley

Bob Jian Huang

Equal Weight

maintain

$36 -> $39

2025-05-19

Reason

Morgan Stanley

Bob Jian Huang

Price Target

$36 -> $39

2025-05-19

maintain

Equal Weight

Reason

Morgan Stanley analyst Bob Jian Huang raised the firm's price target on Bowhead Specialty to $39 from $36 and keeps an Equal Weight rating on the shares. The firm is updating its price targets on stocks under its coverage in the P&C Insurance sector, the analyst tells investors. Results were somewhat mixed depending on the segments, but the firm sees further growth and margin expansion in personal lines, which should be durable in 2025. Heading into 2025, the firm expects broader P&C trend to remain steady, with personal lines and brokers leading on the earnings growth front.

Keefe Bruyette

Meyer Shields

Outperform

maintain

$43 -> $45

2025-05-09

Reason

Keefe Bruyette

Meyer Shields

Price Target

$43 -> $45

2025-05-09

maintain

Outperform

Reason

Keefe Bruyette analyst Meyer Shields raised the firm's price target on Bowhead Specialty to $45 from $43 and keeps an Outperform rating on the shares. Bowhead's current valuation underappreciates its very strong premium growth prospects, the analyst tells investors in a research note.

Piper Sandler

Paul Newsome

Buy

Initiates

$44

2025-04-16

Reason

Piper Sandler

Paul Newsome

Price Target

$44

2025-04-16

Initiates

Buy

Reason

Piper Sandler analyst Paul Newsome initiated coverage of Bowhead Specialty with an Overweight rating and $44 price target. The firm says Bowhead is a high growth specialty insurer with a history of profitability and an experienced management team. owhead is an affiliate of AmFam for statutory purposes which reduces the company's statutory capital requirements, the analyst tells investors in a research note. Piper says the company is operating in high growth profitable markets.

JMP Securities

Matthew Carletti

Buy

Maintains

$38 → $40

2025-04-11

Reason

JMP Securities

Matthew Carletti

Price Target

$38 → $40

2025-04-11

Maintains

Buy

Reason

Citizens JMP analyst Matthew Carletti raised the firm's price target on Bowhead Specialty to $40 from $38 and keeps an Outperform rating on the shares. The firm expects Q1 results to be highlighted by catastrophe losses and ongoing concerns around casualty loss reserves, while tariff uncertainty and the possible impacts on inflation will likely also be a key focus, the analyst tells investors in a research note.

Keefe, Bruyette & Woods

Meyer Sheilds

Buy

Maintains

$44 → $43

2025-04-09

Reason

Keefe, Bruyette & Woods

Meyer Sheilds

Price Target

$44 → $43

2025-04-09

Maintains

Buy

Reason

Keefe Bruyette analyst Meyer Shields lowered the firm's price target on Bowhead Specialty to $43 from $44 and keeps an Outperform rating on the shares.

JP Morgan

Pablo Zuanic

Hold

Maintains

$30 → $35

2025-04-08

Reason

JP Morgan

Pablo Zuanic

Price Target

$30 → $35

2025-04-08

Maintains

Hold

Reason

JPMorgan raised the firm's price target on Bowhead Specialty to $35 from $30 and keeps a Neutral rating on the shares as part of a Q1 preview for the property and casualty sector. The outlook for the P&C sector is positive given ongoing firm pricing, a defensive risk profile, and attractive valuation levels, the analyst tells investors in a research note

See All Ratings

Valuation Metrics

The current forward P/E ratio for Bowhead Specialty Holdings Inc (BOW.N) is 19.46, compared to its 5-year average forward P/E of 21.61. For a more detailed relative valuation and DCF analysis to assess Bowhead Specialty Holdings Inc 's fair value, click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.

Undervalued

5Y Average PE

21.61

Current PE

19.46

Overvalued PE

23.23

Undervalued PE

19.99

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.

Fair

5Y Average EV/EBITDA

13.68

Current EV/EBITDA

13.11

Overvalued EV/EBITDA

15.08

Undervalued EV/EBITDA

12.27

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.

Undervalued

5Y Average PS

2.07

Current PS

1.82

Overvalued PS

2.28

Undervalued PS

1.86